Illumina | 399.6100 / -4.03% |
Date/Time | 03/04 / 22:00 |
Chg. / Chg.(%) | -16.8000 / -4.03% |
Bid | 390.0100 / 6500 |
Ask | 398.0000 / 100 |
Open | 413.3500 |
Previous Close | 416.4100 |
High | 418.3500 |
Low | 395.6900 |
Volume [USD] | 302,802,648.8135 |
Volume [Units] | 1,268,038 |
Price fixings | 5349 |
ISIN | US4523271090 |
Security | ILMN |
Exchange | NASDAQ |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
TradeGate | 332.250 | ![]() |
45 |
Xetra | 330.25 | ![]() |
6 |
Düsseldorf | 332.20 | ![]() |
5 |
Vienna Globa.. | 333.50 | ![]() |
0 |
Berlin | 332.55 | ![]() |
0 |
München | 331.30 | ![]() |
0 |
Lang & Schwa.. | 331.950 | ![]() |
|
Stuttgart | 332.900 | ![]() |
|
gettex | 333.850 | ![]() |
|
NASDAQ | 399.6100 | ![]() |
1,268,038 |
IEX | 399.43 | ![]() |
99,865 |
Cboe US | 398.95 | ![]() |
86,571 |
London Inter.. | 401.42 | 11,851 | |
Mexico | 8,512.00 | ![]() |
138 |
Frankfurt | 340.7500 | 11 |
News
- Myriad Genetics Joins Forces with Intermountain Precision Genomics for a Comprehensive Offering of Germline and Somatic Tumor Testing Services
03/02/2021 / 13:05 - GlobeNewswire - Kura Oncology Reports Fourth Quarter and Full Year 2020 Financial Results
02/24/2021 / 13:20 - GlobeNewswire - Myriad Genetics Delivers 6% Sequential Revenue Growth; Company Continues to Execute Strategic Transformation Plan
02/23/2021 / 22:05 - GlobeNewswire - Seer Appoints Deep Nishar and Mostafa Ronaghi, Ph.D. to its Board of Directors
02/17/2021 / 14:00 - GlobeNewswire - US closes higher, finishes week with new record highs
02/12/2021 / 22:00 - TeleTrader